This information is provided for educational purposes only and does not constitute medical advice
PlexusDx removes those obstacles by offering compounded semaglutide and GLP-1 alternatives directly to patients across all 50 states, with pricing that stays fixed regardless of your dose adjustments and HSA/FSA eligibility that maximizes affordability
We also pride ourselves on managing insurance verifications and the entire prior authorization process, so you dont have to worry about the details
The GLP-1 receptor agonists approved for weight loss include: Zepbound (tirzepatide), Saxenda (liraglutide), and Wegovy (semaglutide)
Get Contacted by Saiontz & Kirk You will be contacted by our law firm to help determine if financial compensation may be available for you and your family
Five studies in over 4,000 patients showed that Ozempic lowered levels of HbA1c (a measure of blood glucose) by between 1.2 and 1.8 percentage points over 10 to 13 months